Turnover
≈ €120,000 estimated
The micro format states no turnover.
MRI SOLUTION
Overview
Lifetime
3 annual accounts with figures on one time axispeak €47,539 (2024)
€39,564▼ 16.8%
peak €29,816 (2024)
€23,599▼ 20.9%
peak €58,054 (2025)
€58,054▲ 68.5%
€19,578▲ 47.3%
Board1 name since 2023
1 directorVIGATO Alexandre Jérôme
Documentsfilings and deeds
22-07-20269 days before the deadline
2025micro format
Gross margin from €47,539 to €39,564Equity from €34,454 to €58,054Debts from €13,289 to €19,578Cash from €32,178 to €66,106
Key points
from the 2025 annual accountsChecked score
97
Excellent
Financially stronger than 76% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025highest value
09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025lowest value
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Founded in 2023
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 3.57, cash €66,106
Equity €58,054 (74.8% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 64% of them on solvency, 75% on liquidity, 80% on profitability and 85% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as MRI SOLUTION has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of MRI SOLUTION itself is lower: < 0.1% within 12 months. It rests on far more data about MRI SOLUTION than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for MRI SOLUTION. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.57 (2.42 in 2024), above the usual 1.5. Short-term debt is 25.2% and cash 85.2% of total assets. 25.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
9 days early
2024
23 days late
2023
61 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 25 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 August (3 of the last 3 accounts filed within 39 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Incorporation
Founding capital of €2,000, 100 shares · Founder: VIGATO Alexandre Jérôme · Appointment: VIGATO Alexandre Jérôme (director) · published on 25-10-2023 · Gazette deed
First establishment
Vier-Windenstraat 148, Molenbeek-Saint-Jean
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MRI SOLUTION Molenbeek-Saint-Jean | €77,631 | €39,564 | 74.8% | - |
| FERLIN NGOUGNI MEDICAL CONSULTING Manage | €65,899 | €36,981 | 63.4% | - |
| AMLB Zedelgem | €82,285 | €57,395 | 72.0% | - |
| GDT IMAGING Amblève | €121,211 | €50,445 | 35.3% | - |
| Meditech Imaging Society Charleroi | €93,404 | €60,081 | 39.5% | - |
| Eleonora Cottone-Apotheker-Klinisch bioloog Ghent | €47,708 | €35,862 | 62.5% | - |
| DENTAAL LABO DEGRAEVE Roeselare | €140,896 | €46,405 | 39.6% | - |
These companies have the same main activity as MRI SOLUTION: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €47,700 and €141,000, founded between 2022 and 2024.
Official details
Source: KBO- Status
- Active since 21-10-2023Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Establishment unit
- 2.352.127.3631080 Molenbeek-Saint-Jean, since 21-10-2023
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- €39,564▼ 16.8%
- €23,599▼ 20.9%
- €58,054▲ 68.5%
- €77,631▲ 62.6%
- Filing
- Filed on 22-07-2026, 9 days before the end of the filing period
Insights on MRI SOLUTION
MRI SOLUTION files the micro format. That format states no turnover. The gross margin rose from €4,769 in 2023 to €39,564 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 22-07-2026, 9 days before the deadline€39,564
▼ 16.8%
€31,253
▼ 19.3%
€23,599
▼ 20.9%
€50,271
▲ 166%
74.8%
▲ 2.6 percentage points
3.57
▲ 1.15
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €120,000. Estimated: probably between €91,000 and €170,000.
Balance sheet
balance sheet total €77,631 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
74.8%
Higher than 63% of 20,764 companies in 2025.
3.57
Higher than 58% of 20,339 companies in 2025.
30.4%
Higher than 65% of 20,620 companies in 2025.
MRI SOLUTION
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: middle half · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet: assets | ||||
20/58 |
77,631 | 47,743 | 8,344 | |
21/28 |
7,783 | 15,565 | - | |
22/27 |
7,783 | 15,565 | - | |
24 |
7,783 | 15,565 | - | |
29/58 |
69,849 | 32,178 | 8,344 | |
40/41 |
3,133 | - | - | |
40 |
3,133 | - | - | |
54/58 |
66,106 | 32,178 | 8,344 | |
490/1 |
610 | - | - | |
| Balance sheet: equity and liabilities | ||||
10/49 |
77,631 | 47,743 | 8,344 | |
10/15 |
58,054 | 34,454 | 4,638 | |
10/11 |
2,000 | 2,000 | 2,000 | |
14 |
56,054 | 32,454 | 2,638 | |
17/49 |
19,578 | 13,289 | 3,706 | |
42/48 |
19,578 | 13,289 | 3,706 | |
44 |
1,206 | 637 | 507 | |
440/4 |
1,206 | 637 | 507 | |
45 |
16,387 | 9,699 | 781 | |
450/3 |
16,387 | 9,699 | 781 | |
47/48 |
1,985 | 2,954 | 2,419 | |
| Income statement | ||||
9900 |
39,564 | 47,539 | 4,769 | |
630 |
7,783 | 7,783 | 1,350 | |
640/8 |
528 | 1,022 | - | |
9901 |
31,253 | 38,734 | 3,419 | |
75/76B |
1 | - | - | |
76B |
1 | - | - | |
65/66B |
185 | 0 | - | |
66B |
185 | 0 | - | |
9903 |
31,069 | 38,734 | 3,419 | |
67/77 |
7,470 | 8,918 | 781 | |
9904 |
23,599 | 29,816 | 2,638 | |
9905 |
23,599 | 29,816 | 2,638 | |
| Appropriation of the result | ||||
9906 |
56,054 | 32,454 | 2,638 | |
14P |
32,454 | 2,638 | - | |
| Document | ||||
The notes to these accounts have 4 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 22-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| 39,036 | 46,517 | 4,769 | ||
| 31,382 | 37,599 | 3,988 | ||
| 0 | 23,348 | - | ||
| 33,928 | 23,833 | - | ||
| 50,271 | 18,889 | 4,638 | ||
| 74.8% | 72.2% | 55.6% | ||
| 3.57 | 2.42 | 2.25 | ||
| 0.34 | 0.39 | 0.80 | ||
| 40.7% | 86.5% | 56.9% | ||
| 30.4% | 62.5% | 31.6% | ||
| over 100 | over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Tangible fixed assets | - | €23,348 | - |
| €7,783 | €7,783 | €1,350 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Insights on MRI SOLUTION
The operating result for 2025 is 19% lower than in 2024.
Debt's share of the balance-sheet total falls from 27.8% to 25.2%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
appointed by deed of 25-10-2023
term without a fixed end
Mandates through the years
1 name, the dashed line is todayVIGATO Alexandre Jérôme
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- VIGATO Alexandre Jérôme
- Director (not named in the articles), appointed by deed of 25-10-2023, still in office
Control
Capital
- Contribution
- €2,000
- Shares
- 100
- Contribution per share
- €20
- Equity per share
- €581 in 2025
- Source
- deed of 25-10-2023
Articles of association
deed of 25-10-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
Shareholders
At incorporation
deed of 25-10-2023 ↗
- VIGATO Alexandre Jérôme 100 shares (100%) · €2,000
Capital transactions
Capital over time
- 25-10-2023 Incorporation · €2,000
- 25-10-2023 Incorporation · €2,000 · 100 shares
Network & group
No group
MRI SOLUTION has no parent and no holdings in its annual accounts. VIGATO Alexandre Jérôme is the only director. MRI SOLUTION shares no director with another company.
At the same address
Vier-windenstraat 148, 1080 Molenbeek-Saint-Jean · 2 other companies| Melhaoui, Amine (sole trader)
establishment since 01-12-2024 |
founded in 2024 1016.664.324 |
| Vigato, Alexandre (sole trader)
establishment since 01-08-2021 |
founded in 2021 0773.549.066 |
Timeline
Timeline
6 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 9 days before the deadline
2025
Annual accounts 2024 filed PDFmicro format · 23 days late
2024
Highest result from 2023 to 2025 net €29,816 ▲1,030% The operating result of €38,734 and the net result of €29,816 are both a record.
Annual accounts 2023 filed PDFmicro format · 61 days late
2023
IncorporationFounding capital of €2,000, 100 shares · Founder: VIGATO Alexandre Jérôme · Appointment: VIGATO Alexandre Jérôme (director) · published on 25-10-20235 points ▸
- Founding capital, €2,000
- Founding capital, €2,000, 100 shares
- Founder, VIGATO Alexandre Jérôme
- Registered office clause, 1080 Molenbeek-Saint-Jean Rue des Quatre-Vents 148–boîte 7
- Director appointment, VIGATO Alexandre Jérôme (director (not named in the articles))
- The deed holds 5 more points.
First establishment Vier-Windenstraat 148, Molenbeek-Saint-Jean
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
MRI SOLUTION was incorporated on 21 October 2023 as a private limited company by one natural person, with a starting capital of €2,000.12 VIGATO Alexandre Jérôme is director of the company, appointed by deed of 25-10-2023.2 Total assets rose from €8,344 in 2023 to €77,631 in 2025.3
Company details
Identity
- Enterprise number
- 1001.475.609
- VAT number
- BE 1001.475.609
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 21-10-2023
- Financial year
- ends on 31 December
- Peppol
- Not found in the Peppol Directory
- Name
- MRI SOLUTION in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 25-10-2023 (in French)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Région de Bruxelles-Capitale”deed of 25-10-2023 (in French)
Activities
NACEBEL 202586910
Medical imaging and medical laboratories main activity
Codes under NACEBEL 2008
86901
Human health activities main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Les prestations de services paramédicaux en imagerie médicale; La mise en œuvre de toutes techniques paramédicales; La consultance et…”deed of 25-10-2023 (in French)
9 activities
- Les prestations de services paramédicaux en imagerie médicale
- La mise en œuvre de toutes techniques paramédicales
- La consultance et formation en santé naturelle et bien-être
- La conception,l'installation,l'organisation et l'exploitation d'un cabinet,d'un centre destiné à dispenser l'ensemble des prestations précitées,d'un club de sport,d'une salle d'entraînement sportif et de remise en condition physique
- L'achat,la vente,l'importation,l'exportation,la location de tout matériel et appareil,et de tous produits en rapport avec les activités ainsi que toutes prestations se rattachant notamment à l'ergothérapie,l'endermologie
- L’organisation,la promotion et l’exploitation d’événements,manifestations,congrès,expositions,séminaires,spectacles,stages ainsi que l’édition,la diffusion et la vente de livres,magazines,cassettes vidéo et DVD,brochures ayant un rapport direct ou indirect avec le secteur médical,paramédical,éducatif,préventif,sportif ou du bien-être
- Diligenter toutes opérations de gestion administrative et financière dans d'autres cabinets,maisons médicales,ou toute autre infrastructure
- L'achat,la vente,l'échange,la construction,la reconstruction,la démolition,la transformation,l'exploitation,la location et la gérance de tous immeubles bâtis,meublés ou non
- L'achat,la vente,l'échange,la mise en valeur,le lotissement,l'exploitation,la location et l'affermage de tous immeubles non bâtis
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Vier-Windenstraat 148 registered office 1080 Molenbeek-Saint-Jean | 21-10-2023 | 2.352.127.363 |
Buildings and parcels at the address
- Ground area
- 923 m²
- Buildings
- 431 m²
- Volume, LiDAR
- 6,002 m³
- Tallest building
- 16.1 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21523B0911/00H013 | 923 m² | 1 · 431 m² | 16.1 m · 5 |